Multicenter Evaluation of the Idylla GeneFusion in Non–Small-Cell Lung Cancer

Footnotes

The authors received no specific funding for this work.

Disclosures: The Idylla prototype cartridges were provided by Biocartis NV, Mechelen, Belgium. L.C.V.K. reports speaker honoraria from AstraZeneca, Lilly, NanoString, and Roche, honoraria for advisory boards from Janssen and Merck, and grant and in-kind research support from AstraZeneca , Bayer , Invitae , Illumina , Janssen , Merck , NanoString and Roche ; E.S. reports disclosures not directly relevant to the submitted work, which includes providing lectures for Bio-Rad, Novartis, Roche, Biocartis, Illumina, Pfizer, AstraZeneca, and Agena Bioscience, advisory board presence for AstraZeneca, Roche, Pfizer, Novartis, Bayer, Lilly, BMS, Amgen, Biocartis, Illumina, Agena Bioscience, and MSD/Merck, and grants and in-kind research support from Abbott , Pfizer , Biocartis , BMS , AstraZeneca , Invitae /Archer, Bayer , Bio-Rad , Roche , Agena Bioscience , CC Diagnostics , and Boehringer Ingelheim ; B.B. reports providing lectures for Novartis, Roche, Pfizer, AstraZeneca, Lilly, BMS, and ThermoFisher, and research grants from Roche and ThermoFisher . J.S. reports advisory honoraria from MDK, and speaker honoraria from Biocartis, Merck, Targos, and AstraZeneca; S.M.-B. reports personal fees from AstraZeneca, Roche, Novartis, GSK, MSD, Targos, Molecular Health, Merck, and Amgen, and personal fees and nonfinancial support from BMS and Janssen; P.D. reports disclosures not directly relevant to the submitted work, which includes consulting fees/advisory board membership from AstraZeneca, Pfizer, Bayer, and Eli Lilly, speaker's honoraria from Pfizer and AstraZeneca, and grant research support from AstraZeneca , Pfizer , Eli Lilly , EMD Serrono , Bayer , and Novartis ; A.M.-L. reports personal fees from Amgen, AstraZeneca, Lilly, Pfizer, and Roche outside the submitted work, and speaker fees from Biocartis NV. Other authors have no conflicts of interest to declare.

留言 (0)

沒有登入
gif